Related Experiment Videos
Platelet MAO activity in primary degenerative dementia
The American Journal of Psychiatry
|January 1, 1984
Summary
Primary degenerative dementia patients show significantly higher platelet monoamine oxidase (MAO) activity compared to healthy elderly individuals. This elevated MAO activity in dementia patients exceeds that typically observed with normal aging.
Area of Science:
- Neuroscience
- Biochemistry
- Gerontology
Background:
- Platelet monoamine oxidase (MAO) activity is a biomarker of interest in neurological disorders.
- Aging is associated with changes in MAO activity, but its role in dementia requires further clarification.
Purpose of the Study:
- To investigate and compare platelet MAO activity in patients with primary degenerative dementia and age-matched healthy controls.
- To determine if dementia is associated with altered MAO activity beyond normal aging effects.
Main Methods:
- Enzyme activity assays were performed on platelets isolated from 24 patients diagnosed with primary degenerative dementia.
- Platelet MAO activity was also measured in 20 neurologically healthy elderly individuals serving as controls.
Main Results:
- Patients with primary degenerative dementia exhibited significantly higher platelet MAO activity compared to the control group.
- The observed increase in MAO activity in demented patients was more pronounced than the elevation typically associated with the normal aging process.
Conclusions:
- Elevated platelet MAO activity may serve as a potential biochemical marker for primary degenerative dementia.
- These findings suggest a specific link between MAO dysregulation and dementia pathophysiology, distinct from age-related changes.